Brain, Vol. 114, No. 2, 801-810, 1991
© 1991 Oxford University Press
research-article |
PATTERNS OF BLOOD-BRAIN BARRIER BREAKDOWN IN INFLAMMATORY DEMYELINATION
1Multiple Sclerosis NMR Research Group, Institute of Neurology London, UK 2Multiple Sclerosis Society Laboratory, Department of Neurochemistry, Institute of Neurology London, UK
Correspondence to:
Correspondence to: Professor W. I. McDonald, Institute of Neurology, Queen Square, London WCIN 3BG, UK.
The evolution of the changes in the blood-brain barrier (BBB) in chronic relapsing experimental allergic encephalomyelitis (CREAE), a model of immune-mediated demyelination, has been studied by magnetic resonance imaging (MRI); gadolinium-DTPA (Gd-DTPA) was used to detect BBB breakdown by both quantitative and qualitative techniques. Animals with acute EAE were examined for comparison. In animals with CREAE an approximately linear relationship was found between the mean number of lesions enhancing with Gd-DTPA seen per MRI slice and the severity of clinical disability at relapse. In addition, a direct relationship was seen between the duration of clinical relapse and the duration of enhancement with Gd-DTPA for lesions associated with the relapse. Lesions studied in animals having entered a progressive phase of disease showed the most sustained BBB breakdown. These observations suggest that BBB breakdown is important in the development of clinical signs in inflammatory demyelination. In CREAE, areas of focal enhancement with Gd-DTPA could usually be clearly defined at a time of clinical relapse. In slices free of focal lesions, no abnormal Gd-DTPA leakage could be detected using a quantitative method. In contrast, in acute EAE no focal lesions were visible, but significant leakage was detected by measurement. No change was found in T2 relaxation times in CREAE or acute EAE.
The pattern of BBB breakdown in inflammatory demyelination evolves from a diffuse shortlived disturbance in acute EAE to a more focal and prolonged breakdown in animals with chronic relapsing and progressive disease. The broad similarities in the pattern of BBB breakdown seen in CREAE and multiple sclerosis support the hypothesis that the initial vascular changes in the human disease are due to inflammation which could be mediated immunologically.
Received December 8, 1989. Revised May 1, 1990. Accepted May 16, 1990.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P S Piraino, T A Yednock, S B Freedman, E K Messersmith, M A Pleiss, and S J Karlik Suppression of acute experimental allergic encephalomyelitis with a small molecule inhibitor of {alpha}4 integrin Multiple Sclerosis, December 1, 2005; 11(6): 683 - 690. [Abstract] [PDF] |
||||
![]() |
R. Polavarapu, M. C. Gongora, J. A. Winkles, and M. Yepes Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Increases the Permeability of the Neurovascular Unit through Nuclear Factor-{kappa}B Pathway Activation J. Neurosci., November 2, 2005; 25(44): 10094 - 10100. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Steinbrecher, T. Weber, T. Neuberger, A. M. Mueller, X. Pedre, G. Giegerich, U. Bogdahn, P. Jakob, A. Haase, and C. Faber Experimental Autoimmune Encephalomyelitis in the Rat Spinal Cord: Lesion Detection with High-Resolution MR Microscopy at 17.6 T AJNR Am. J. Neuroradiol., January 1, 2005; 26(1): 19 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F Lythgoe, N. R Sibson, and N. G Harris Neuroimaging of animal models of brain disease Br. Med. Bull., March 1, 2003; 65(1): 235 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Cotton, H. L. Weiner, F. A. Jolesz, and C. R.G. Guttmann MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals Neurology, February 25, 2003; 60(4): 640 - 646. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Jordan, H. I. McFarland, B. K. Lewis, N. Tresser, M. A. Gates, M. Johnson, M. Lenardo, L. A. Matis, H. F. McFarland, and J. A. Frank Serial MR Imaging of Experimental Autoimmune Encephalomyelitis Induced by Human White Matter or by Chimeric Myelin-Basic and Proteolipid Protein in the Common Marmoset AJNR Am. J. Neuroradiol., June 1, 1999; 20(6): 965 - 976. [Abstract] [Full Text] |
||||
![]() |
L. Calza, L. Giardino, M. Pozza, C. Bettelli, A. Micera, and L. Aloe Proliferation and phenotype regulation in the subventricular zone during experimental allergic encephalomyelitis: In vivo evidence of a role for nerve growth factor PNAS, March 17, 1998; 95(6): 3209 - 3214. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. d. Vries, J. Kuiper, A. G. d. Boer, T. J. C. V. Berkel, and D. D. Breimer The Blood-Brain Barrier in Neuroinflammatory Diseases Pharmacol. Rev., June 1, 1997; 49(2): 143 - 156. [Abstract] [Full Text] [PDF] |
||||






